Finding China’s Moderna is a financial long shot
Published on: Wednesday 05 January 2022
Finding China’s answer to Moderna comes with huge health warnings for investors. The $87 billion biotechnology giant’s Covid-19 vaccines have inspired copycats in the People’s Republic, where cities ...
News source: https://www.reuters.com/breakingviews/finding-chinas-moderna-is-financial-long-shot-2022-01-06/
